Patents by Inventor Patrick Lecine

Patrick Lecine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210373004
    Abstract: A support for a multiplex binding experiment is functionalized with at least two different polypeptides. The polypeptides are provided in a reaction mixture along with their cognate binding partners. The polypeptides have high affinity for their cognate binding partners provided in the reaction mixture. The polypeptides and their cognate binding partners can be used in immunoassays.
    Type: Application
    Filed: November 18, 2019
    Publication date: December 2, 2021
    Inventors: Patrick LECINE, Christophe VEDRINE, Adrien LUGARI
  • Publication number: 20120244155
    Abstract: Compositions and methods comprising high affinity monoclonal antibody conjugates against several DC receptors are described herein. The inventors prepared fusion proteins with antigens for DC-targeting vaccine generation by conjugating several M. tuberculosis protein antigens with high affinity monoclonal antibodies against several DC receptors with a view to developing novel human vaccines based on in vivo DC-targeting. The findings of studies described herein indicate that vaccines bearing TB antigens can recall a potent memory antigen-specific T cell response in vitro resulting in IFN? secretion.
    Type: Application
    Filed: March 20, 2012
    Publication date: September 27, 2012
    Applicants: BAYLOR RESEARCH INSTITUTE, Agence Nationale de Recherches Sur le Sida, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Patrick Lecine, Yves Levy, Gerard Zurawski, Jacques F. Banchereau